Log In

Owen Brendan Wallace Edit Profile

chemist , researcher

Owen Brendan Wallace, Irish chemist, researcher. Achievements include patent for anti-Alzheimer's disease compounds, anti-Human Immunodeficiency Virus compounds, selective estrogen receptor modulators and oral anti-diabetics; co-inventor of multiple clinical candidates; research in medicinal chemistry and drug discovery. Samuel K. Bushnell fellow Yale University, New Haven, 1992, Dox fellow Yale University, New Haven, 1994.

Background

Wallace, Owen Brendan was born on February 24, 1969 in Dublin, Ireland. Came to the United States, 1991. Son of Brendan J. and Ursula (O'Neill) Wallace.

Education

Bachelor of Science with 1st class honors, University College, Cork, Ireland, 1991. Master of Science, Yale University, 1992. Doctor of Philosophy, Yale University, 1995.

Career

Research investigator Bristol-Myers Squibb, Wallingford, Connecticut, 1995-2000. Research scientist Eli Lilly & Company, Indianapolis, 2000—2003, head discovery chemistry research and technical, 2003—2005, director neuroscience and obesity chemistry, 2005—2009, senior director neuroscience chemistry, 2009—2010. Site science leader Lilly Research Center, England, since 2010.

Achievements

  • Achievements include patent for anti-Alzheimer's disease compounds, anti-Human Immunodeficiency Virus compounds, selective estrogen receptor modulators and oral anti-diabetics. Co-inventor of multiple clinical candidates. Research in medicinal chemistry and drug discovery.

Works

  • Other Work

    • Contributor chapter to book and articles to professional journals.

Membership

Member Royal Society Chemistry (chartered chemist), American Chemical Society.

Connections

Married Erin Elizabeth McCann, 1999. Children: Emma, Rachel.

father:
Brendan J. Wallace

mother:
Ursula (O'Neill) Wallace

spouse:
Erin Elizabeth McCann

child:
Rachel Wallace

child:
Emma Wallace